课题基金 / 基金详情

Molecular basis for Rift Valley fever phlebovirus NSs protein function

Molecular basis for Rift Valley fever phlebovirus NSs protein function
裂谷热白斑病毒 NSs 蛋白功能的分子基础
批准号:
MR/W018608/1
负责人:
Ulrich Schwarz-Linek
金额:
$103.59万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Ulrich Schwarz-Linek的其他基金

相似基金

相关文献

中文摘要
翻译
裂谷热是一种危险的疾病,由一种由蚊子传播的病毒在非洲大部分地区和阿拉伯半岛传播。它造成了巨大的经济损失,导致受感染牲畜群的流产率非常高(“堕胎风暴”)。该病毒还经常通过接触受感染的动物或通过蚊子叮咬传播给人类。在大多数人类疾病中,症状类似于流感或脑膜炎期间出现的症状。然而,在大约10%的病例中会出现严重疾病,包括脑炎(脑炎)和出血热(类似埃博拉病毒),这些往往是致命的。令人担忧的是,裂谷热还与人类高堕胎率有关,这增加了另一种广泛传播的病毒对未出生生命造成严重损害的可能性,这让人想起寨卡病毒。动物疫苗可用于预防裂谷热的暴发,但这些疫苗并不完全安全和/或完全有效。目前还没有可用的人类疫苗或治疗方法。裂谷热病毒很有可能在世界上的新地区出现,例如,因为全球变暖帮助蚊子能够将病毒从原来的栖息地传播到温带地区。由于裂谷热流行的可能性很高,而且没有治疗方法或安全的疫苗可用,裂谷热是世界卫生组织认为迫切需要优先研究的八种疾病之一。裂谷热的疫苗和药物开发需要详细了解病毒是如何致病的。与其他病毒一样,裂谷热病毒必须抑制受感染动物和人类的免疫反应,才能繁殖和传播。它主要通过使用一种分子--NSS蛋白质来实现这一点。这就像一把分子瑞士军刀--蛋白质的不同部分执行许多不同的生物活动。NSS的详细工作原理尚不清楚,主要是因为到目前为止,该蛋白质的三维结构尚不清楚。在缺乏完整结构的情况下,我们获得了NSS中央部分的结构,这将使我们能够剖析NSS的生物学功能。NSS耐人寻味的特性之一是在感染细胞中形成独特的细长结构(细丝),特别是在存储和获取遗传信息的细胞核中。这些细丝可能是病毒致病的重要因素。它们扰乱了读出遗传信息所需的机械。它们也可能与裂谷热病例中观察到的堕胎有关。我们的分子结构揭示了NSS蛋白质如何形成线状组装,但尚不清楚这些如何聚集在一起形成细胞核中的细丝。我们现在希望利用我们的分子洞察力和强大的新成像方法,主要是冷冻电子显微镜,在非常高的放大倍数下观察感染细胞中NSS细丝的样子。这些信息将有助于我们了解NSS的瑞士军刀活动。例如,我们将能够看到细胞核中的NSS是否与其他分子相互作用。我们还将为NSS蛋白质配备分子手柄,使我们能够分离该蛋白质及其与之结合的其他蛋白质。同样的分子手柄可以用来让NSS在显微镜下发光。这也将使我们能够发现NSS是如何进入细胞核的。我们将利用到目前为止获得的知识来设计NSS的变体和片段,使我们能够获得缺失的结构信息。我们希望解剖NSS的结构和功能将帮助我们了解几种危险的病毒是如何致病的,并将为制造能够破坏NSS细丝并可能用于治疗裂谷热的药物铺平道路。
英文摘要
Rift Valley fever is a dangerous disease caused by a virus that is transmitted by mosquitos in most parts of Africa and the Arabian Peninsula. It causes large economic losses inducing a very high rate of abortions ("abortion storms") in infected livestock herds. The virus is also frequently transmitted to humans through contact with infected animals, or through mosquito bites. In most cases of human disease symptoms are similar to those seen during flu or meningitis. However, in about 10% of cases serious diseases develop, including encephalitis (brain inflammation) and haemorrhagic fever (similar to Ebola) that are often fatal. Worryingly, Rift Valley fever has also been linked to high rates of abortions in humans, raising the possibility of another widespread virus that causes severe damage to unborn life, reminiscent of Zika. Animal vaccines are available for preventing outbreaks of Rift Valley fever, but these are not completely safe and/or fully effective. No human vaccines or treatments are available. Rift Valley fever virus has a high potential to emerge in new regions in the world, for instance because global warming helps mosquitos capable of transmitting the virus spread from their original habitats into temperate zones. Because of its high potential for widespread epidemics, and because no treatments or safe vaccines are available, Rift Vally fever is one of eight diseases that according to the WHO are an urgent research priority.Vaccine and drug development for Rift Valley fever requires a detailed understanding of how the virus causes disease. Like other viruses, Rift Valley fever virus has to suppress the immune response of infected animals and humans in order to multiply and spread. It achieves this mainly by using one molecule, the NSs protein. This operates akin to a molecular Swiss army knife - a number of different biological activities are carried out by different parts of the protein. How NSs works in detail is poorly understood, mainly because up to now the three-dimensional structure of the protein was unknown. While the complete structure is still lacking, we obtained the structure of the central part of NSs, which now will enable us to dissect the biological functions of NSs. One of the intriguing properties of NSs is the formation of distinct elongated structures (filaments) in infected cells, specifically in the cell nucleus where genetic information is stored and accessed. These filaments may be important for the virus to cause disease. They disrupt the machinery required to read out the genetic information. They may also be linked to the abortions observed in Rift Valley fever cases. Our molecular structure revealed how the NSs protein can form thread-like assemblies, but it is unclear how these would come together to form filaments in cell nuclei.We now would like to use our molecular insights and powerful new imaging methods, mainly cryo-electron microscopy, to see at very high magnification what NSs filaments look like in infected cells. This information will help us understand the Swiss army knife activities of NSs. For instance we will be able to see if NSs in cell nuclei interacts with other molecules. We will also equip the NSs protein with molecular handles that will allow us to isolate the protein together with other proteins that it binds to. The same molecular handles can be used to make NSs glow under a microscope. This will also allow us to find out how NSs travels into the cell nucleus. We will use our knowledge gained so far to design variants and fragments of NSs that will allow us to obtain the missing structural information. We expect that dissecting structure and functions of NSs will help us understand how several dangerous viruses cause disease, and will pave the way to making drugs that would disrupt NSs filaments and may be used to treat Rift Valley fever.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A molecular basis for autoimmune sequelae of streptococcal infections
  • 批准号:
    MR/N009681/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $73.93万
  • 财政年份:
    2016
  • 负责人:
    Ulrich Schwarz-Linek
  • 依托单位:
Covalent host targeting by thioester domains of Gram-positive pathogens
  • 批准号:
    MR/K001485/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $87.5万
  • 财政年份:
    2012
  • 负责人:
    Ulrich Schwarz-Linek
  • 依托单位:
国内基金
海外基金
基于Volatility Basis-set方法对上海大气二次有机气溶胶生成的模拟
  • 批准号:
    41105102
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2011
  • 负责人:
    王杨君
  • 依托单位:
求解Basis Pursuit问题的数值优化方法
  • 批准号:
    11001128
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    王丽平
  • 依托单位:
TB方法在有机和生物大分子体系计算研究中的应用
  • 批准号:
    20773047
  • 项目类别:
    面上项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2007
  • 负责人:
    吕文彩
  • 依托单位: